TABLE 5.
Implementation of Hib vaccine in countries of the WHO South East Asia Regiona
| Country | Yr of introduction | NIP | Formulation in 2019 | Schedule in 2019 | Coverage of Hib3 in 2019 (%) | Yr in which coverage reached ≥50% |
|---|---|---|---|---|---|---|
| Bangladesh | 2009 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 98 | 2009 |
| Bhutan | 2011 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 97 | 2012 |
| Democratic People’s Republic of Korea | 2012 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 97 | 2013 |
| India | 2015 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 89 | 2016 |
| Indonesia | 2014 | Yes | DTwP/Hib/HepB | 2, 3, 4, 18 mo | 79 | 2015 |
| Maldives | 2013 | Yes | DTwP/Hib/HepB | 2, 4, 6 mo | 99 | 2013 |
| Myanmar | 2012 | Yes | DTwP/Hib/HepB | 2, 4, 6 mo | 91 | 2013 |
| Nepal | 2009 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 91 | 2011 |
| Sri Lanka | 2008 | Yes | DTwP/Hib/HepB | 2, 4, 6 mo | 99 | 2010 |
| Thailand | 2019 | Yes | DTwP/Hib/HepB | 2, 4, 6 mo | ND | ND |
| Timor-Leste | 2012 | Yes | DTwP/Hib/HepB | 6, 10, 14 wks | 83 | 2013 |
a
Annual birth cohort, 33.8 million. Children aged <5 years, 169.7 million. Eighty-nine percent of target population immunized with three doses of Hib (Hib3) in 2019 (based on WHO-UNICEF estimates) (156). NIP, national immunization program; ND, no data. Abbreviations of vaccine antigens: D, diphtheria; T, tetanus; wP, whole-cell pertussis; Hib, Haemophilus influenzae type b; HepB, hepatitis B virus surface antigen; IPV, inactivated poliovirus.